Skip to main content

United States Statins Market 2017 (Atorvastatin (Lipitor), Fluvastatin (Lescol) ,Lovastatin and Pitavastatin (Livalo)) Industry Research Report

Press Release   •   Aug 10, 2017 03:17 EDT

In this report, the United States Statins Market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Click Here To Get Request Sample: http://globalqyresearch.com/download-sample/253681 

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Statins in these regions, from 2012 to 2022 (forecast).

United States Statins market competition by top manufacturers/players, with Statins sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Pfizer
Merck
Teva
Amgen
Abbott
AstraZeneca
Novartis
SUN Pharma
Torrent Pharmaceuticals
GlaxoSmithKline
HanAll BioPharma
JX Pharmaceuticals
Aurobindo Pharma
Abbvie
Cerenis Therapeutics

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Atorvastatin (Lipitor)
Fluvastatin (Lescol)
Lovastatin
Pitavastatin (Livalo)
Pravastatin (Pravachol)
Rosuvastatin (Crestor)
Simvastatin (Zocor)

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Statins for each application, including
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

If you have any special requirements, please let us know and we will offer you the report as you want.

Ask Query Here:Jay@globalqyresearch.com or Sales@globalqyresearch.com

Table of Contents

United States Statins Market Report 2017
1 Statins Overview
1.1 Product Overview and Scope of Statins
1.2 Classification of Statins by Product Category
1.2.1 United States Statins Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Statins Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Atorvastatin (Lipitor)
1.2.4 Fluvastatin (Lescol)
1.2.5 Lovastatin
1.2.6 Pitavastatin (Livalo)
1.2.7 Pravastatin (Pravachol)
1.2.8 Rosuvastatin (Crestor)
1.2.9 Simvastatin (Zocor)
1.3 United States Statins Market by Application/End Users
1.3.1 United States Statins Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 United States Statins Market by Region
1.4.1 United States Statins Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Statins Status and Prospect (2012-2022)
1.4.3 Southwest Statins Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Statins Status and Prospect (2012-2022)
1.4.5 New England Statins Status and Prospect (2012-2022)
1.4.6 The South Statins Status and Prospect (2012-2022)
1.4.7 The Midwest Statins Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Statins (2012-2022)
1.5.1 United States Statins Sales and Growth Rate (2012-2022)
1.5.2 United States Statins Revenue and Growth Rate (2012-2022)

2 United States Statins Market Competition by Players/Suppliers
2.1 United States Statins Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Statins Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Statins Average Price by Players/Suppliers (2012-2017)
2.4 United States Statins Market Competitive Situation and Trends
2.4.1 United States Statins Market Concentration Rate
2.4.2 United States Statins Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Statins Manufacturing Base Distribution, Sales Area, Product Type

3 United States Statins Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Statins Sales and Market Share by Region (2012-2017)
3.2 United States Statins Revenue and Market Share by Region (2012-2017)
3.3 United States Statins Price by Region (2012-2017)

4 United States Statins Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Statins Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Statins Revenue and Market Share by Type (2012-2017)
4.3 United States Statins Price by Type (2012-2017)
4.4 United States Statins Sales Growth Rate by Type (2012-2017)

5 United States Statins Sales (Volume) by Application (2012-2017)
5.1 United States Statins Sales and Market Share by Application (2012-2017)
5.2 United States Statins Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Statins Players/Suppliers Profiles and Sales Data
6.1 Pfizer
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Statins Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Pfizer Statins Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Merck
6.2.2 Statins Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Merck Statins Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Teva
6.3.2 Statins Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Teva Statins Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Amgen
6.4.2 Statins Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Amgen Statins Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Abbott
6.5.2 Statins Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Abbott Statins Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 AstraZeneca
6.6.2 Statins Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 AstraZeneca Statins Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Novartis
6.7.2 Statins Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Novartis Statins Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 SUN Pharma
6.8.2 Statins Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 SUN Pharma Statins Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Torrent Pharmaceuticals
6.9.2 Statins Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Torrent Pharmaceuticals Statins Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 GlaxoSmithKline
6.10.2 Statins Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 GlaxoSmithKline Statins Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 HanAll BioPharma
6.12 JX Pharmaceuticals
6.13 Aurobindo Pharma
6.14 Abbvie
6.15 Cerenis Therapeutics

7 Statins Manufacturing Cost Analysis
7.1 Statins Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Statins

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Statins Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Statins Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Statins Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Statins Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Statins Sales Volume Forecast by Type (2017-2022)
11.3 United States Statins Sales Volume Forecast by Application (2017-2022)
11.4 United States Statins Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer

To Purchase this Premium Report: http://globalqyresearch.com/checkout-form/0/253681

About Us:

Global QYResearch is the one spot destination for all your research needs. Global QYResearch holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decision by understanding their requirements and suggesting best possible collection matching their needs.

Contact Us:

Unit1, 26 Cleveland Road, South Woodford, London, E182AN, United Kingdom

Contact: +44 20 3239 2407